Potential of osteopontin in the management of epithelial ovarian cancer

.blurhash-client-img { display: none !important; }

Open Access

|Jan 2019

Authors

Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University Ljubljana, Ljubljana, Slovenia

Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University Ljubljana, Ljubljana, Slovenia

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Department of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, Slovenia

Department of Gynaecology and Obstetrics, Faculty of Medicine, University Ljubljana, Ljubljana, Slovenia

Department of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, Slovenia

Department of Gynaecology and Obstetrics, Faculty of Medicine, University Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2019-0003 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Language: English

Page range: 105 - 115

Submitted on: Sep 7, 2018

Accepted on: Dec 27, 2018

Published on: Jan 31, 2019

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2019 Katarina Cerne, Benjamin Hadzialjevic, Erik Skof, Ivan Verdenik, Borut Kobal, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.